Tonghua Golden-Horse Pharmaceutical Industry Co Ltd (000766) - Total Liabilities

Latest as of March 2026: CN¥2.42 Billion CNY ≈ $354.78 Million USD

Based on the latest financial reports, Tonghua Golden-Horse Pharmaceutical Industry Co Ltd (000766) has total liabilities worth CN¥2.42 Billion CNY (≈ $354.78 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Tonghua Golden-Horse Pharmaceutical Industry Co Ltd - Total Liabilities Trend (1994–2025)

This chart illustrates how Tonghua Golden-Horse Pharmaceutical Industry Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See Tonghua Golden-Horse Pharmaceutical Indu (000766) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Tonghua Golden-Horse Pharmaceutical Industry Co Ltd Competitors by Total Liabilities

The table below lists competitors of Tonghua Golden-Horse Pharmaceutical Industry Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
All Ring Tech Co Ltd TWO:6187	Taiwan	NT$2.12 Billion
KEPCO Engineering & Construction KO:052690	Korea	₩239.41 Billion
H&E Equipment Services Inc NASDAQ:HEES	USA	$2.07 Billion
Dalmia Bharat Limited NSE:DALBHARAT	India	Rs150.01 Billion
Doosan Fuel Cell Co Ltd KO:336260	Korea	₩835.48 Billion
Gentera S.A.B. de C.V MX:GENTERA	Mexico	MX$77.38 Billion
H B Fuller Company NYSE:FUL	USA	$3.15 Billion
Seek Ltd AU:SEK	Australia	AU$1.95 Billion

Liability Composition Analysis (1994–2025)

This chart breaks down Tonghua Golden-Horse Pharmaceutical Industry Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Tonghua Golden-Horse Pharmaceutical Indu worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.90	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.05	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.51	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Tonghua Golden-Horse Pharmaceutical Industry Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Tonghua Golden-Horse Pharmaceutical Industry Co Ltd (1994–2025)

The table below shows the annual total liabilities of Tonghua Golden-Horse Pharmaceutical Industry Co Ltd from 1994 to 2025.

Year	Total Liabilities	Change
2025-12-31	CN¥2.17 Billion ≈ $317.00 Million	-2.78%
2024-12-31	CN¥2.23 Billion ≈ $326.06 Million	+1.23%
2023-12-31	CN¥2.20 Billion ≈ $322.09 Million	-4.99%
2022-12-31	CN¥2.32 Billion ≈ $338.99 Million	+0.66%
2021-12-31	CN¥2.30 Billion ≈ $336.78 Million	-13.99%
2020-12-31	CN¥2.68 Billion ≈ $391.58 Million	+31.69%
2019-12-31	CN¥2.03 Billion ≈ $297.35 Million	+62.65%
2018-12-31	CN¥1.25 Billion ≈ $182.81 Million	-4.51%
2017-12-31	CN¥1.31 Billion ≈ $191.45 Million	+14.56%
2016-12-31	CN¥1.14 Billion ≈ $167.12 Million	-40.18%
2015-12-31	CN¥1.91 Billion ≈ $279.39 Million	+204.96%
2014-12-31	CN¥626.09 Million ≈ $91.62 Million	+27.28%
2013-12-31	CN¥491.91 Million ≈ $71.98 Million	+78.69%
2012-12-31	CN¥275.29 Million ≈ $40.28 Million	+0.95%
2011-12-31	CN¥272.69 Million ≈ $39.90 Million	-11.09%
2010-12-31	CN¥306.71 Million ≈ $44.88 Million	+7.48%
2009-12-31	CN¥285.36 Million ≈ $41.76 Million	+10.81%
2008-12-31	CN¥257.51 Million ≈ $37.68 Million	-5.51%
2007-12-31	CN¥272.53 Million ≈ $39.88 Million	-3.38%
2006-12-31	CN¥282.05 Million ≈ $41.27 Million	-73.43%
2005-12-31	CN¥1.06 Billion ≈ $155.33 Million	+0.67%
2004-12-31	CN¥1.05 Billion ≈ $154.30 Million	-7.90%
2003-12-31	CN¥1.14 Billion ≈ $167.53 Million	+10.08%
2002-12-31	CN¥1.04 Billion ≈ $152.18 Million	+4.62%
2001-12-31	CN¥994.08 Million ≈ $145.47 Million	-15.82%
2000-12-31	CN¥1.18 Billion ≈ $172.81 Million	+312.65%
1999-12-31	CN¥286.19 Million ≈ $41.88 Million	+22.30%
1998-12-31	CN¥234.01 Million ≈ $34.24 Million	+33.40%
1997-12-31	CN¥175.42 Million ≈ $25.67 Million	+8.43%
1996-12-31	CN¥161.79 Million ≈ $23.67 Million	+48.05%
1995-12-31	CN¥109.28 Million ≈ $15.99 Million	+77.17%
1994-12-31	CN¥61.68 Million ≈ $9.03 Million	--

About Tonghua Golden-Horse Pharmaceutical Industry Co Ltd

SHE:000766 China Drug Manufacturers - Specialty & Generic

Market Cap

$3.47 Billion

CN¥23.70 Billion CNY

Market Cap Rank

#4605 Global

#805 in China

Share Price

CN¥24.52

Change (1 day)

-2.35%

52-Week Range

CN¥18.46 - CN¥29.50

All Time High

CN¥29.50